Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus/Tacrolimus vs Tacrolimus/Methotrexate for GVHD Prophylaxis
NCT00406393Phase 3Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Nov 2006
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sirolimus in graft-versus-host disease (GVHD), sponsored by Medical College of Wisconsin. Started Nov 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00406393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406393.